Scientific consulting
Assay design and development, method validation, analytical performance evaluation and scientific expertise for LC-MS/MS based clinical diagnostics, including therapeutic drug monitoring, drugs of abuse testing and toxicology.
From the first feasibility question to post-market surveillance: six areas of work, available individually or as continuous support.
Assay design and development, method validation, analytical performance evaluation and scientific expertise for LC-MS/MS based clinical diagnostics, including therapeutic drug monitoring, drugs of abuse testing and toxicology.
Guidance through the regulatory process under EU IVDR and FDA requirements: classification, technical documentation, the Performance Evaluation Report under Annex XIII and conformity assessment. Expertise in ISO 13485, 15189 and 17025.
Planning and support of clinical performance studies, cooperation with key opinion leaders and healthcare professionals, and communication between medical affairs, development and clinical partners.
Strategic advice on the role of CDx in personalised medicine and biosimilar programmes: the build-or-partner decision, alignment of approval pathways and improvement of analytical performance.
Strategic direction of clinical laboratories, setup and maintenance of quality management systems, gap analyses, automation concepts and process optimisation.
Support for the global launch of IVD products with experience in EU, US and Asian markets. Building and facilitating cooperation with reference laboratories, commercial partners and academic groups, including in matrix structures across time zones and working cultures.
Consulting is delivered mostly remotely. On-site visits at manufacturers, laboratories and partners are possible by arrangement.
A fixed weekly capacity from 10 hours over several months. Suited to programmes that need scientific and regulatory expertise on an ongoing basis without creating a full-time position.
Bounded tasks with a clear output: validation plan, gap analysis, Performance Evaluation Report, CDx strategy paper or study protocol.
Independent expert assessment of an existing dossier, method or strategy. Short engagement, written opinion, no long-term commitment.
A first conversation takes 30 minutes and clarifies where your project stands scientifically and in regulatory terms.